Metropolis Healthcare, an India-based diagnostics laboratory chain, has completed its initial public offering (IPO) on the Bombay Stock Exchange and the National Stock Exchange of India, raising INR12 billion (approximately USD174 million). The company did not issue any primary shares in the offering, which consisted entirely of shares sold by Metropolis founder Sushil Shah and global alternative asset manager The Carlyle Group. Carlyle reportedly sold 7 million shares in the offering at the top end of the proposed price range of INR877 to INR880 (USD12.66 to USD12.71), generating gross proceeds of INR6.5 billion (USD94 million). Canada-based pension fund CDPQ and the private equity arm of Edelweiss Financial Services were among a group of 26 investors who committed INR5.3 billion (USD77 million) as anchor investors in the IPO.